Endo Creditors Eye Plan for Drugmaker’s Sale Through Bankruptcy

Creditors of Endo International Plc, the drugmaker facing opioid-related lawsuits, are discussing a deal that involves putting the entire company up for sale through bankruptcy, according to people with knowledge of the situation.

The drugmaker will likely file for Chapter 11 in New York, with certain first-lien lenders vying to apply their debt holdings toward a bid for the company’s assets, said the people, who asked not to be identified because the matter is private.

Representatives for Endo didn’t respond to emails and phone calls seeking comment. A representative for the company’s financial adviser, PJT Partners Inc., declined to ...